#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Splenic marginal zone lymphoma Acute lymphocytic leukaemia recurrent Alport's syndrome Gaucher's disease type I Andersen-Tawil syndrome Mantle cell lymphoma stage III Hereditary ataxia Pancreatic carcinoma Prostate cancer Alveolar proteinosis Osteomyelitis Burkitt's lymphoma Pulmonary arterial hypertension Polymyositis Acromegaly More trials…

    Learn about Rare Diseases

    Advanced systemic mastocytosis – Diagnostics Friedreich’s ataxia – Diagnostics Adrenogenital syndrome Angiosarcoma non-metastatic – Life with Disease Anaplastic thyroid cancer – Treatment Rett syndrome – Diagnostics Myxofibrosarcoma – Trials in Disease Hyperoxaluria – Basic Information Fragile X syndrome – Basic Information Myelodysplastic syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ag13909 Dazukibart Thiamine Fluoxetine Hydrochloride Lenacapavir Tiapride Vrdn-001 Remimazolam Febuxostat Hemihydrate Flecainide Epacadostat Salbutamol Sulfate Oxybuprocaine Hydrochloride Blu-263 Phosphate Fluorescein Sodium Keto-Valine Calcium POLYMYXIN B SULFATE Acetylcysteine Polatuzumab Vedotin YOHIMBINE HYDROCHLORIDE More therapies…

    Learn about Your Condition

    Open angle glaucoma Endometrial cancer recurrent HIV infection Small for dates baby Pneumothorax Compulsive sexual behaviour Angina pectoris Ovarian epithelial cancer Cardiac failure Lymphatic malformation Pulmonary sarcoidosis Laryngeal leukoplakia Autoimmune hepatitis Cushing's syndrome Post procedural complication More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Varsinais-Suomen hyvinvointialue

Varsinais-Suomen hyvinvointialue

Kiinamyllynkatu 4-8, Turku, 20520, Finland

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Drug Combination for Advanced Cancer Patients with Known Molecular Profile – FINPROVE Study

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • Abemaciclib
    • Alectinib
    • Apalutamide
    Finland

  • Study on Treating Acute Myeloid Leukemia in Children and Adolescents Using Daunorubicin, Mitoxantrone, and a Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Daunorubicin
    • Daunorubicin Hydrochloride
    • Cytarabine
    Belgium Denmark Finland The Netherlands Norway Spain +1

  • Study on Ependymoma Treatment in Children, Adolescents, and Young Adults Using Cisplatin, Cyclophosphamide, Etoposide, and a Drug Combination

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Ependymoma
    Investigated Drugs:
    • Sodium Valproate
    • Cisplatin
    • Cyclophosphamide
    Austria Belgium Czechia Denmark Finland France +7

  • Study of drug combinations including irinotecan, ifosfamide, vincristine, dactinomycin, regorafenib and other agents for children and adults with rhabdomyosarcoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Rhabdomyosarcoma
    Investigated Drugs:
    • Dactinomycin
    • Temozolomide
    • Vinorelbine Tartrate
    Austria Belgium Czechia Denmark Finland France +10

  • Study on Istradefylline for Reducing Brain Inflammation in Patients with Progressive Multiple Sclerosis

    Recruiting

    2 1 1
    Investigated Drugs:
    • Istradefylline
    Finland

  • Study on MB-CART2019.1 for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Not Eligible for High-Dose Chemotherapy and Stem Cell Transplantation

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • B-cell lymphoma recurrent
    • B-cell lymphoma refractory
    Investigated Drugs:
    • Polatuzumab Vedotin
    • Zamtocabtagene Autoleucel
    • Bendamustine Hydrochloride
    Austria Belgium Croatia Czechia Finland France +9

  • Study of AZD5305 with Abiraterone Acetate and Darolutamide in Men with Metastatic Castration-Sensitive Prostate Cancer

    Recruiting

    3 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    Investigated Drugs:
    • Darolutamide
    • Saruparib
    • Abiraterone Acetate
    Austria Belgium Finland France Germany Hungary +5

  • Study on Long-Term Safety of Enzalutamide, Abiraterone, and Prednisolone for Patients with Prostate Cancer from Previous Enzalutamide Trials

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Abiraterone
    • Enzalutamide
    • Prednisolone
    Austria Belgium Czechia Denmark Finland France +9

  • Study on the Use of Iron Oxide Nanoparticles in MRI to Detect Lymph Node Metastasis in Patients with Newly Diagnosed Rectal Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Metastases to lymph nodes
    • Rectal cancer
    Finland

  • Long-Term Follow-Up Study for Patients Treated with Idecabtagene Vicleucel or Lisocabtagene Maraleucel for Cancer

    Recruiting

    4 1 1
    Investigated Drugs:
    • CC-97540
    • Idecabtagene Vicleucel
    • Lisocabtagene Maraleucel
    Austria Belgium Czechia Denmark Finland France +11
Previous Page
1 2 3 4
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!